Literature DB >> 26526612

Co-silencing of human Bub3 and dynein highlights an antagonistic relationship in regulating kinetochore-microtubule attachments.

Patrícia M A Silva1, Álvaro A Tavares2, Hassan Bousbaa3.   

Abstract

We previously reported that the spindle assembly checkpoint protein Bub3 is involved in regulating kinetochore-microtubule (KT-MT) attachments. Also, Bub3 was reported to interact with the microtubule motor protein dynein. Here we examined how this interaction contributes to KT-MT attachments. Depletion of Bub3 or dynein induced misaligned chromosomes, consistent with their role in KT-MT attachments. Unexpectedly, co-silencing of both proteins partially suppressed the misalignment phenotype and restored chromosome congression. Consistent with these observations, KT-MT attachments in co-depleted cells were stable, able to drive chromosome congression, and produce inter- and intra-kinetochore stretch, indicating they are functional. We suggest that a mutual antagonism exists between Bub3 and dynein to ensure optimal KT-MT attachments.
Copyright © 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antagonistic interaction; Bub3; Chromosome congression; Dynein; Kinetochore–microtubule interaction; Spindly

Mesh:

Substances:

Year:  2015        PMID: 26526612     DOI: 10.1016/j.febslet.2015.10.017

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

Review 1.  BUB3, beyond the Simple Role of Partner.

Authors:  Patrícia M A Silva; Hassan Bousbaa
Journal:  Pharmaceutics       Date:  2022-05-18       Impact factor: 6.525

2.  Antagonizing the spindle assembly checkpoint silencing enhances paclitaxel and Navitoclax-mediated apoptosis with distinct mechanistic.

Authors:  Ana C Henriques; Patrícia M A Silva; Bruno Sarmento; Hassan Bousbaa
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

3.  Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein.

Authors:  Mariana Nunes; Patrícia M A Silva; Ricardo Coelho; Carla Pinto; Albina Resende; Hassan Bousbaa; Gabriela M Almeida; Sara Ricardo
Journal:  Front Oncol       Date:  2021-10-21       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.